1. Home
  2. IGR vs IRWD Comparison

IGR vs IRWD Comparison

Compare IGR & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CBRE Global Real Estate Income Fund of Beneficial Interest

IGR

CBRE Global Real Estate Income Fund of Beneficial Interest

N/A

Current Price

$4.72

Market Cap

645.2M

Sector

Finance

ML Signal

N/A

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

N/A

Current Price

$3.68

Market Cap

741.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IGR
IRWD
Founded
2004
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
645.2M
741.8M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
IGR
IRWD
Price
$4.72
$3.68
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$4.94
AVG Volume (30 Days)
763.9K
2.8M
Earning Date
01-01-0001
05-26-2026
Dividend Yield
13.93%
N/A
EPS Growth
N/A
1400.00
EPS
N/A
0.15
Revenue
N/A
$298,276,000.00
Revenue This Year
N/A
$57.95
Revenue Next Year
N/A
$4.39
P/E Ratio
N/A
$23.17
Revenue Growth
N/A
8.88
52 Week Low
$4.20
$0.55
52 Week High
$5.37
$5.78

Technical Indicators

Market Signals
Indicator
IGR
IRWD
Relative Strength Index (RSI) 39.47 42.79
Support Level $4.65 $3.08
Resistance Level $5.04 $3.93
Average True Range (ATR) 0.08 0.33
MACD -0.04 -0.03
Stochastic Oscillator 22.22 39.72

Price Performance

Historical Comparison
IGR
IRWD

About IGR CBRE Global Real Estate Income Fund of Beneficial Interest

CBRE Clarion Global Real Estate Income Fund is a United States-based diversified, closed-end management investment company. Its primary objective is high current income, and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities, which includes common stocks, preferred securities, warrants, and convertible securities issued by real estate companies, such as real estate investment trusts. Under normal market conditions, it invests in real estate equity securities of companies domiciled predominantly in developed countries.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: